Fixed dose combination therapy in the treatment of hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. A multicenter cohort study of primary hypertension in Korea: study design and interim analysis of the Korean registry of target organ damage in hypertension (KorHR).Clinical hypertension · 2017
   Article
2. Drug target optimization in chronic myeloid leukemia using innovative computational platform.Scientific reports · 2015
   Article
3. Prediction of drug combinations by integrating molecular and pharmacological data.PLoS computational biology · 2011
   Article
4. Nebivolol/Hydrochlorothiazide : a new fixed-dose combination for effective simplified antihypertensive therapy.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2008
   Article
5. Combination therapy as first-line treatment for hypertension.Current hypertension reports · 2004
   Review
6. Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study).Current therapeutic research, clinical and experimental · 2004
   Article
7. A study of use of fixed dose combinations in Ahmedabad, India.Indian journal of pharmacology
   Observational

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as